Professional Documents
Culture Documents
Aman (MGN 1o1)
Aman (MGN 1o1)
On
Cipla Limited
2020-2021
Leadership In CoreMarkets
* Be among the top 3 in home markets
and legacy emerging markets
*Be among the fastest growth in
emerging economies and Specially
business.
Commercial Excellence
*Accelerated revenue growth and
sustainable margin expansion
Financial
Highlights
TOTAL INCOM E FROM
OPERATIONS
Operational Highlights
CSR HIGHLIGHTS
Cipla Foundation envisions and executes Viola’s Corporate Social Responsibility
In the last year ,we have reached out to over 2,20,000 individuals in the community across initiatives in Health/Education/Skilling
Health
Education
Skilling
Our people,
Our
Pride on innovative work
Our emphasis
culture Helps our One Cipla family
pursue our Purpose of 'Caring for
Life’s.
Beyond Drugs and Devices
Outcomes change when mindsets change,
be it Disruptive business ideas, dispelling
myths to Breathe freely or supporting
primary healthcare Projects around the
world.
Making Medicines, Making a
Difference
Our diverse portfolio of
drugs spread across
therapies
and geographies is the
result of our
uncompromising
Commitment to research,
quality and manufacturing
About this Report
Cipla takes pride in present in the Annual Report 2017-2018 ,with a first time
adoption of integrated reporting framework by the International Integrated
Reporting Council.Integrated reporting lays down standard which enable
companies to present stakeholders with a broader and a more comprehensive
perspective on business health & performance.Cipla being one of India’s first
adopters of integrated reporting in the pharma sector,views this report as one
more step in our legacy of pioneering advances in the pharma sector.